Moderna will being testing its coronavirus vaccine in children as young as 12
Moderna Inc will begin testing its COVID-19 vaccine in children, who are capable of passing on the virus, to high-risk group in its large, late-stage trial. According to clinicaltrials.gov, a registry of clinical trials run by the US National Library of Medicine, the study will enroll 3,000 participants between ages 12 and 17. Half of … Read more